期刊文献+

西维来司钠的合成 被引量:2

Synthesis of Sivelestat Sodium
下载PDF
导出
摘要 目的 :研究西维来司钠的合成路线及工艺。方法 :以甘氨酸为起始原料 ,与 2 硝基苯甲酰氯缩合 ,还原 ,得N (2 氨基苯甲酰基 )甘氨酸 ,然后与 4 新戊酰氧基苯磺酰氯缩合 ,氢氧化钠成盐 ,制得西维来司钠。结果 :合成了目标化合物 ,其结构经红外光谱、核磁共振氢谱及质谱确证。结论 :该方法操作简便 ,适于工业化生产。 Objective: To improve the preparation of Sivelestat sodium. Methods: Sivelestat sodium was synthesized from glycine through amidation, hydrogenation and acychloridization. Results: The structure of the target compound was confirmed by IR, 1HNMR and MS. Conclusion: The method is easy for synthesis and suitable for industrial manufacturing.
作者 郭炼伟 张灿
出处 《药学进展》 CAS 2005年第2期85-87,共3页 Progress in Pharmaceutical Sciences
关键词 弹性蛋白酶抑制剂 西维来司钠 合成 Inhibitor of humane neutrophil elastase Sivelestat sodium Synthesis
  • 相关文献

参考文献5

  • 1李伟,卞红平,宁奇.西维来司钠的合成[J].化学世界,2004,45(1):29-31. 被引量:7
  • 2黄伟,吴雪松,岑均达.西维来司钠的合成[J].中国医药工业杂志,2003,34(8):369-370. 被引量:4
  • 3Katsuhiro I, Yoshinobu A, Tadao O.Preparation of p-subs-tituted phenylester of pivalic acid elastase inhibitor and pharmaceutical compositions[P].EP:347168, 1989-12-20. 被引量:1
  • 4Katsuhiro I, Hirohisa W.Preparation of an acylglycine derivative as an elastase inhibitor[P].EP:539223, 1993-04-28. 被引量:1
  • 5Lee C R, Plosker G L, McTavish D.A review of its pharma-codynamic and pharmacokinetic properties, and therapeutic potential as anantiemetic[J].Drugs, 1993, 46(5):925-943. 被引量:1

二级参考文献8

  • 1[1]Kawabata K, Suzuki M, Sugitani M, et al. Ono5046, a novel inhibitor of human neutrophil elastase [J]. Biochem Biophys Res Commun, 1991,177 (2):814-820. 被引量:1
  • 2[2]Zeiher B G, Matsuoka S, Kawabata K, et al. Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics [J]. Crit Care Med, 2002,30 (5 Suppl ):S281-S287. 被引量:1
  • 3[3]Katsuhiro I, Yoshinobu A, Tadao O. Preparation of p-substituted phenyl ester of pivalic acid elastase inhibitor and pharmaceutical compositions[P]. EP:347168,1989-12-20. (CA 1990,133:114810w) 被引量:1
  • 4[4]Katsuhiro I, Hirohisa W. Preparation of an acylglycine derivative as an elastase inhibitor[P]. EP:539 223,1993-04-28. (CA 1993,119:181226x) 被引量:1
  • 5[5]Taschner E, Wasielewski G. New esterification procedures in peptide chemistry[J]. Ann, 1961,640,136-139. 被引量:1
  • 6Katsuhiro I, Hirohisa W. Preparation of an acylglyeine derivative as an elastase inhibitor [P]. EP:539223,1993-04-28. (CA 1993,119:181226x). 被引量:1
  • 7Katsuhiro I, Yoshinobu A, Tadao O. Preparation of p-substituted phenyl ester of pivalic acid as elastase inhibitor and pharmaceutical compositions [P]. EP:347168,1989-12-20. (CA 1990,113:114810w). 被引量:1
  • 8The Merck Index[M]. 13th ed, 8629. 被引量:1

共引文献8

同被引文献16

  • 1张莉,李文刚,马敬红,梁伯润.热致液晶共聚酯60PHB/PEN的合成及其表征[J].合成技术及应用,2003,18(4):1-4. 被引量:3
  • 2陈祖鑫,韦天辉,蒋奕峰,曾健.H_2O_2漂白活化剂异壬酰氧苯磺酸钠的合成研究[J].中华纸业,2006,27(2):47-50. 被引量:9
  • 3陈荣圻.REACH法规是什么?[J].印染助剂,2007,24(2):45-47. 被引量:1
  • 4Tamakuma S, Shiba T, Hirasawa H, et al. A phase Ⅲ clinical study of a neutrophil elastase inhibitor, ONO-5046-Na in SIRS patients[J]. Rinsho Iyaku, 1998, 14(7) :289 - 318. 被引量:1
  • 5Eiher BG, Matsuoka SM, Kawabata K, et al. Neutrophil elastase and acute lung injury: Prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics[ J ]. Critical Care Med, 2002, 30:S281 -S287. 被引量:1
  • 6Awabata K, Suzuki M, Sugitani M, et al. ONO-5046, a novel inhibitor of human neutrophil elastase [ J ].Biochem Biophys Res Commun, 1991, 177(10) :814 -820. 被引量:1
  • 7Katsuhiro I, Takanori O, Yoshisuke N. Non-peptidic inhibitors of human neutrophil elastase: the design and synthesis of sulfonanilide-containing inhibitors [J ].Bioorg Med Chem, 1996, 4 (12) : 2115 - 2134. 被引量:1
  • 8Katsuhiro I, Hirohisa W. Preparation of an acylglycine derivative as an elastase inhibitor[P]. EP: 539223,1993 - 04 - 28. 被引量:1
  • 9Yoshisuke N, Yoshihiro O, Setauko F. Clarification of mechanism of human sputum elastase inhibition by a new inhibitor, ONO-5046, using electrospray ionization mass spectrometry[J]. Bioorg Med Chem Lett, 2002,12(17) :2349 - 2353. 被引量:1
  • 10张连红,田彦文.硫酸钙晶须催化合成三羟甲基丙烷三丙烯酸酯[J].分子科学学报,2009,25(6):375-378. 被引量:7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部